piracetam has been researched along with Gastroduodenal Ulcer in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsimmerman, IaS | 1 |
| Buliusin, VIa | 1 |
| Besschetnova, AI | 1 |
| Shabanov, PD | 1 |
1 review available for piracetam and Gastroduodenal Ulcer
| Article | Year |
|---|---|
[Ulcer disease: challenging problems of etiology, pathogenesis, differential treatment].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Disease Management; Drug Resistance, Multipl | 2012 |
1 other study available for piracetam and Gastroduodenal Ulcer
| Article | Year |
|---|---|
[Hyperbaric oxygenation and nootropic agents in the treatment of exacerbation of peptic ulcer].
Topics: Acute Disease; Adult; Central Nervous System Agents; Combined Modality Therapy; Etimizol; Female; Hu | 1987 |